Ultragenyx Pharmaceutical RARE
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 23.00 | -80 | -129 | -9.44 | 1,532 | |
| 2025Q3 | 30.08 | 9 | -224.89 | -180 | -14.45 | 1,190 |
| 2025Q2 | 36.36 | 151 | -77.79 | -115 | -8.78 | 1,306 |
| 2025Q1 | 36.21 | 144 | -75.63 | -151 | -10.73 | 1,312 |
| 2024Q4 | 42.07 | 255 | -44.30 | -133 | -8.77 | 1,503 |
| 2024Q3 | 55.55 | 347 | -34.27 | -134 | -8.46 | 1,538 |
| 2024Q2 | 41.10 | 432 | -45.96 | -132 | -9.00 | 1,618 |
| 2024Q1 | 46.69 | 140 | -82.12 | -171 | -12.20 | 1,307 |
| 2023Q4 | 47.82 | 275 | -80.22 | -123 | -9.03 | 1,491 |
| 2023Q3 | 35.65 | 32 | -198.64 | -160 | -12.52 | 1,238 |
| 2023Q2 | 46.13 | 129 | -91.46 | -160 | -11.86 | 1,311 |
| 2023Q1 | 40.10 | 220 | -57.24 | -164 | -11.20 | 1,383 |
| 2022Q4 | 46.33 | 352 | -36.97 | -152 | -9.60 | 1,545 |
| 2022Q3 | 41.41 | 469 | -42.74 | -245 | -16.68 | 1,618 |
| 2022Q2 | 59.66 | 678 | -21.45 | -158 | -11.70 | 1,321 |
| 2022Q1 | 72.62 | 796 | -17.72 | -152 | -10.48 | 1,384 |
| 2021Q4 | 84.09 | 923 | -13.19 | -122 | -8.14 | 1,522 |
| 2021Q3 | 90.19 | 934 | -7.66 | -73 | -4.87 | 1,485 |
| 2021Q2 | 95.35 | 972 | -12.08 | -122 | -7.87 | 1,512 |
| 2021Q1 | 113.86 | 1,055 | -12.33 | -136 | -8.11 | 1,598 |